Nita Radhakrishnan: A Huge Thanks to TIF for Supporting Midterm PHOCON 2025 in Noida
Nita Radhakrishnan, Additional Professor and HOD, Department of Pediatric Hematology-Oncology, shared an honoring post on LinkedIn:
”A huge thanks to Thalassaemia International Federation (TIF) for their support for Midterm PHOCON 2025 at Noida from 31 July to 3 Aug 2025.
With your support, we were able to bring focus to comprehensive care, patient voices, and emerging therapies — ensuring that thalassemia remains a priority in our discussions. The workshops on thalassemia transfusion, MRI based monitoring of iron overload as well as the CME on advances in thalassemia care were very well appreciated.
TIF’s guidance has been instrumental in shaping the dialogue on better care for individuals living with thalassemia. Thank you for standing with us in this mission.”
Stay updated on the latest news in Hematology with Hemostasis Today.
-
Apr 6, 2026, 16:39Dhinesh Selvaraju: FDA Approves Narsoplimab (Yartemlea) as 1st Treatment for TA-TMA in Adults and Children
-
Apr 6, 2026, 16:38Linda Vorberg: A Detailed Analysis on The Usefulness of CT for DL-Based Stroke Lesion Segmentation
-
Apr 6, 2026, 16:37Colleen Hearn: Telestroke Helps Resource-Limited Facilities Gain Access to Unavailable Expertise
-
Apr 6, 2026, 16:37Nicolas Hubacz: AI Maps Neuroplasticity in Stroke Recovery – How the Brain Adapts After Injury
-
Apr 6, 2026, 16:36Cristina de Diego Alonso: Movement Is Not Just an Exercise, It Is The Rhythm of Daily Life
-
Apr 6, 2026, 16:35Charles Okyere Boadu: What Is The Most Likely Cause of Persistent Thrombocytopenia Despite Transfusion?
-
Apr 6, 2026, 16:34Tumor Mutations and VTE Risk – New Insights from a 12,500-Patient Cancer Study – JTH
-
Apr 6, 2026, 16:31Wolfgang Miesbach: New Real-World Data Reveal Ongoing Burden in Moderate-to-Severe Haemophilia A
-
Apr 6, 2026, 16:26Heghine Khachatryan։ Targeting High Risk Antiphospholipid Syndrome in Pregnancy with Hydroxychloroquine